Pain management in children

The Gulf Pain Management Drugs Industry is Expected to Reach $1+ Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021
Health, Pharmaceutical, Pain, Nervous system, Branches of biology, Nociception, Acute pain, Palliative care, Pain management, Chronic pain, Pain management in children

The "Gulf Pain Management Drugs Market by Drug Class, Indication, Pain Type: Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gulf Pain Management Drugs Market by Drug Class, Indication, Pain Type: Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
  • The Gulf Pain Management Drugs Market was valued at $851.08 million in 2019, and is projected to reach $1,047.91 million by 2027, registering a CAGR of 3.2%.
  • The length of the pain would range from acute pain for short term to chronic pain for long term.
  • The Gulf pain management drugs market is segmented on the basis of drug class, indication, pain type, and region.

Pain Relief Technologies and Clarity Science Release Interim Clinical Trial Results for the Kailo Pain Patch®; Results Show a Significant Decrease in Pain Severity, Pain Interference, and Decrease in Concurrent Medication Usage, Including Opioids

Retrieved on: 
Monday, January 11, 2021
Retail, Pharmaceutical, General Health, Women, Seniors, MEN, Clinical trials, Specialty, Family, Science, Biotechnology, Consumer, Other Science, Health, Research, Nervous system, Branches of biology, Acute pain, Nociception, Palliative care, Analgesics, Pain management, Pain, Transdermal analgesic patch, Anesthesia, Pain management in children

The results have been published today in Anesthesia and Pain Research, an international peer-reviewed journal devoted to the clinical practice of anesthesia and pain medicine.

Key Points: 
  • The results have been published today in Anesthesia and Pain Research, an international peer-reviewed journal devoted to the clinical practice of anesthesia and pain medicine.
  • This interim analysis showed a marked and a significant decrease in pain severity and pain interference scores while using the Kailo Pain Patch, as well as a significant decrease in concurrent medication usage, said Hurwitz.
  • Topical analgesics, including pain relief patches, have proven a valuable strategy in the management of mild to moderate levels of pain.
  • PAIN RELIEF TECHNOLOGIES LLC, based in Sandy, Utah, manufactures and distributes the Kailo Pain Patch, part of its pain portfolio of products, to millions of pain sufferers around the world.

New Recommendations Steer Doctors Away from Opioids to Treat Pain in Adolescent Athletes

Retrieved on: 
Monday, August 31, 2020
Perception, Acute pain, Nociception, Palliative care, Pediatrics, Pain management, Pain, Opioid, Chronic pain, Pain management in children, Pediatric psychology

This is especially true for adolescent athletes in whom inadequate or inappropriate pain management can lead to a lifetime of consequences including an increased risk of opioid misuse.

Key Points: 
  • This is especially true for adolescent athletes in whom inadequate or inappropriate pain management can lead to a lifetime of consequences including an increased risk of opioid misuse.
  • "Adolescents are often initially exposed to opioids through prescriptions to treat pain," said Stanley A.
  • "This paper gives health care providers, including team physicians, pediatricians and athletic trainers, a roadmap to navigate the diagnosis and treatment of chronic and acute pain in adolescent athletes."
  • It also is imperative to address pediatric pain appropriately to decrease the likelihood of developing persistent or chronic pain issues into adulthood."

Heron Therapeutics Receives Positive CHMP Opinion for ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain

Retrieved on: 
Friday, July 24, 2020
Pain, Perception, Acute pain, Palliative care, Morphine, Opioid, Bupivacaine, Surgery, Postoperative nausea and vomiting, Pain management in children

The CHMP's positive opinion is based on the results of Heron's two Phase 3 studies of ZYNRELEF.

Key Points: 
  • The CHMP's positive opinion is based on the results of Heron's two Phase 3 studies of ZYNRELEF.
  • ZYNRELEF demonstrated significantly reduced pain and opioid use through 72 hours compared to bupivacaine solution, the current standard-of-care anesthetic for postoperative pain control.
  • ZYNRELEF significantly reduced pain intensity through 72 hours postsurgery, significantly reduced the use of opioid medications following surgery and significantly increased the proportion of patients who required no postoperative opioid medications.
  • The CHMP recommended that ZYNRELEF be indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults.

Alleviating Confusion around Pain Management Recommendations

Retrieved on: 
Tuesday, April 7, 2020
Perception, Nociception, Acute pain, Palliative care, Pain management, Chronic pain, Opioid, Pain, Draft:Primary Care Occupational Therapy Annotated Bibliography, Pain management in children

PLYMOUTH MEETING, Pa., April 7, 2020 /PRNewswire/ --An article published today offers new clarity around the use of prescription opioids in pain management for people with a diagnosis or history of cancer and chronic pain.

Key Points: 
  • PLYMOUTH MEETING, Pa., April 7, 2020 /PRNewswire/ --An article published today offers new clarity around the use of prescription opioids in pain management for people with a diagnosis or history of cancer and chronic pain.
  • "That means ensuring access to appropriate, safe pain management, while not contributing to inappropriate opioid use and addiction.
  • The article delves deeper into the different pain management guidelines and provided tools for determining how and why they differ.
  • It concludes by stating that "pain management is a complex and multifactorial challenge," and suggests further utilization of clinical practice guidelines as a resource to help inform policy, coverage determinations, and treatment decisions for safe, appropriate pain management.

BridgeHealth Partners With eMindful to Address the Stress and Prolonged Pain of Delayed Surgeries Due to COVID-19

Retrieved on: 
Tuesday, April 7, 2020
Professional services, Health, Surgery, Insurance, Managed care, General Health, Perception, Nociception, Acute pain, Pain, Suffering, Chronic pain, Opioid, Anxiety, Pain management in children, Atypical trigeminal neuralgia, eMindful, BridgeHealth

In many cases, members have been left without an expected surgery date or a clear plan, creating additional stress and uncertainty.

Key Points: 
  • In many cases, members have been left without an expected surgery date or a clear plan, creating additional stress and uncertainty.
  • Issues such as limited mobility, chronic pain, anxiety and even depression have led individuals to choose surgery as the next step.
  • We have a decade of firsthand knowledge of the pain and stress encountered by those for whom an elective surgery is critical.
  • "As procedures are prolonged and opioid misuse continues, we need alternative methods to manage pain and associated costs," said Mary Pigatti, CEO, eMindful.

Government of Canada announces funding to help people living with chronic pain

Retrieved on: 
Tuesday, March 3, 2020
Perception, Acute pain, Nociception, Palliative care, Pain management, Pain, Opioid, Chronic condition, Chronic pain, Draft:Primary Care Occupational Therapy Annotated Bibliography, Pain management in children

The Government of Canada knows the importance of ensuring that people living with pain have access to the care and support they need.

Key Points: 
  • The Government of Canada knows the importance of ensuring that people living with pain have access to the care and support they need.
  • This funding will provide Canadians and health care practitioners with specific tools, training, and strategies related to chronic pain management.
  • Whether it's developing chronic pain management strategies or tools to inform on opioids, this funding will help millions of Canadians affected by chronic pain.
  • "This innovative approach in which pharmacists, in consultation with physicians, help patients to use pain medication safely, will reduce barriers to care for people living with chronic pain.

Bioness Introduces Improved Training Platform for Surgeons Expanding Their Practice to Include the StimRouter Peripheral Nerve Stimulator

Retrieved on: 
Thursday, December 19, 2019
Medicine, Medical specialties, Perception, Pain management, Chronic pain, Nociception, Surgical specialties, Pain, Palliative care, Pain management in children, Failed back syndrome

The expanded and improved training aids and programs will assist surgeons looking to offer their patients new, advanced approaches to treating chronic pain.

Key Points: 
  • The expanded and improved training aids and programs will assist surgeons looking to offer their patients new, advanced approaches to treating chronic pain.
  • The newest training video addition reinforces the StimRouter as highly adaptable, targeted, minimally invasive procedure.
  • Currently, there are approximately 250 surgeons in 3 continents using the StimRouter.
  • StimRouter is approved by the FDA to treat chronic pain of peripheral nerve origin, excluding pain in the craniofacial region.

Healthpointe Implements Chronic Pain Programs to Fight Opioid Epidemic

Retrieved on: 
Tuesday, October 15, 2019
Pain, Perception, Medicine, Nociception, Acute pain, Opioids, Medical terminology, Chronic pain, Chronic condition, Opioid-induced hyperalgesia, Pain management in children

Healthpointe has developed two chronic pain programs to help patients suffering from chronic pain decrease their reliance on opioid medications.

Key Points: 
  • Healthpointe has developed two chronic pain programs to help patients suffering from chronic pain decrease their reliance on opioid medications.
  • Unfortunately, for chronic pain patients, opioid medications are taken for longer periods of time and at higher doses to help decrease their pain.
  • For chronic pain patients, traditional drug rehabilitation programs are not the right fit due to a lack of focus on the patient's chronic pain.
  • As a result, Healthpointe has realized the need for chronic pain programs that will address opioid use in patients with chronic pain.

The Global Pain Therapeutics Market, 2019: GPCR & Nerve Growth Factor-based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 30, 2019
Health, Pharmaceutical, Pain, Perception, Medicine, Nociception, Acute pain, Chronic pain, Opioid, Neuropathic pain, Nonsteroidal anti-inflammatory drug, Pain management in children, Draft:Common practices in pain management

The "Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes" report has been added to ResearchAndMarkets.com's offering.
  • The moderate-to-severe pain space continues to be dominated by opioids, which are increasingly being reformulated to offer abuse resistance, whereas mild pain is effectively treated with non-steroidal anti-inflammatory drugs (NSAIDs).
  • However, significant unmet needs remain, as chronic pain subtypes-particularly neuropathic pain-do not respond well to existing therapies.
  • Understand the current disease landscape with an overview of etiology, pathophysiology, disease classification and staging systems and epidemiology for major pain subtypes.